Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT02509754
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT02509754
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02509754. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function
- Acronym
- AFARC-LVF
- Condition
- Persistent Atrial Fibrillation
- Condition
- Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction
- Intervention (Procedure)
- Atrial fibrillation catheter ablation
- Intervention (Procedure)
- Rate control
- Lead sponsor
- University of Turin, Italy
- Collaborator
- Centro Cardiologico Monzino
- Collaborator
- Humanitas Research Hospital IRCCS, Rozzano-Milan
- Collaborator
- University of Padova
- Collaborator
- Policlinico Casilino ASL RMB
Record details
- Record id
cardio:ct-nct02509754- Content hash
3e62ce8db77e6c6f5374be8b179178de00f7669532528ea1efab37c4532600b6